A randomized, placebo-controlled, double-blind study evaluating leuprolide acetate depot treatment before myomectomy**Supported in part by a grant from Takeda-Abbott Research and Development, North Chicago, Illinois, and by grant 7-M01-RR02635-01 from the General Clinical Research Center, Brigham and Women’s Hospital.††Presented at the American Fertility Society, November 13–16, 1989, San Francisco, California.
Author:
Publisher
Elsevier BV
Subject
Obstetrics and Gynecology,Reproductive Medicine
Reference10 articles.
1. Treatment of leiomyomata with intranasal or subcutaneous leuprolide, a gonadotropin-releasing hormone agonist;Friedman;Fertil Steril,1987
2. A randomized, double-blind trial of a gonadotropin-releasing hormone agonist (leuprolide) with or without medroxyprogesterone acetate in the treatment of leiomyomata uteri;Friedman;Fertil Steril,1988
3. A randomized, placebo-controlled, double-blind study evaluating the efficacy of leuprolide acetate depot in the treatment of uterine leiomyomata;Friedman;Fertil Steril,1989
4. Toward removing uterine fibroids without surgery: subcutaneous infusion of a luteinizing hormone-releasing hormone agonist commencing in the luteal phase;Healy;J Clin Endocrinol Metab,1986
5. Long-acting gonadotropin hormone-releasing hormone analog used to treat uteri;Coddington;Fertil Steril,1986
Cited by 112 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Novel insights into post-marketing AEs associated with leuprorelin: A comprehensive analysis utilizing the FAERS database;Heliyon;2024-08
2. Caesarean Myomectomy to Prevent Immediate or Interval Myomectomy, Hysterectomy and Postpartum Hemorrhage;Journal of Obstetrics, Gynecology and Cancer Research;2021-08-01
3. Macrophages and Immune Responses in Uterine Fibroids;Cells;2021-04-22
4. Quercetin and indole-3-carbinol inhibit extracellular matrix expression in human primary uterine leiomyoma cells;Reproductive BioMedicine Online;2020-04
5. A Comprehensive Review of the Pharmacologic Management of Uterine Leiomyoma;BioMed Research International;2018
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3